Nicholas Financial Files 8-K Amendment

TL;DR

NICHOLAS FINANCIAL (NICK) filed an 8-K/A amendment, likely clarifying prior disclosures.

AI Summary

Nicholas Financial, Inc. filed an amendment (8-K/A) on August 29, 2024, to its report originally dated May 15, 2024. This amendment pertains to Regulation FD Disclosure and includes financial statements and exhibits. The filing does not appear to introduce new material information beyond the original report's scope.

Why It Matters

This filing is an amendment to a previous report, indicating a correction or addition to information previously disclosed by Nicholas Financial, Inc.

Risk Assessment

Risk Level: low — The filing is an amendment to a previous report and does not appear to contain new material information that would significantly alter the company's risk profile.

Key Players & Entities

• NICHOLAS FINANCIAL, INC. (company) — Registrant
• May 15, 2024 (date) — Date of earliest event reported
• August 29, 2024 (date) — Date of report (amendment)
• Regulation FD Disclosure (disclosure) — Item Information
• Financial Statements and Exhibits (document) — Item Information

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value per share NICK NASDAQ Glo
• $18.4 m — x for a total purchase consideration of $18.4 million, which was paid in cash pursuant
• $0.8 million — l and accrued interest of approximately $0.8 million under the Term Loan Advances into 421 s
• $1,792.55 — on stock at the share purchase price of $1,792.55 and purchased an additional 1,674 share
• $3.0 million — e of $1,792.55 per share for a total of $3.0 million. These transactions concurrently execut

Filing Documents

• nick-20240515.htm (8-K/A) — 59KB
• nick-ex99_1.htm (EX-99.1) — 622KB
• nick-ex99_2.htm (EX-99.2) — 580KB
• nick-ex99_3.htm (EX-99.3) — 418KB
• img246915618_0.jpg (GRAPHIC) — 25KB
• img247839139_0.jpg (GRAPHIC) — 25KB
• 0000950170-24-101833.txt ( ) — 1958KB
• nick-20240515.xsd (EX-101.SCH) — 26KB
• nick-20240515_htm.xml (XML) — 7KB

01 Regulation FD

Item 7.01 Regulation FD. The information in this Item 7.01, including the exhibit hereto, (x) shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and (y) shall not be incorporated by reference into any filing of the Company with the Securities and Exchange Commission, whether made before or after the date hereof, regardless of any general incorporation language in such filings (unless the Company specifically states that the information or exhibit in this particular report with respect to Item 7.01 are incorporated by reference).

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. a. Financial Statements of Business Acquired. The historical audited consolidated financial statements of Amplex and its subsidiaries as of October 31, 2023 and 2022 and for the years ended October 31, 2023 and 2022, including the notes related thereto and the related report of Bolinger, Segars, Gilbert & Moss, LLP, Amplex's independent auditor, as of February 16, 2024 are filed as Exhibit 99.1 and incorporated herein by reference. The historical unaudited interim condensed consolidated financial statements of Amplex and its subsidiaries as of April 30, 2024 and 2023 and for the six months ended April 30, 2024 and 2023, including the notes related thereto and the related review report of Bolinger, Segars, Gilbert & Moss, LLP, Amplex's independent accountants, as of August 27, 2024 are filed as Exhibit 99.2 and incorporated herein by reference. b. Pro Forma Financial Information Unaudited pro forma condensed consolidated statements of operations of the Company and Amplex for the three months ended June 30, 2024 and 2023, respectively, and the notes related thereto are filed as Exhibit 99.3 and incorporated herein by reference. Exhibit Index Exhibit No. Description 99.1 Audited consolidated financial statements of Amplex and its subsidiaries as of October 31, 2023 and 2022 and for the years ended October 31, 2023 and 2022, including the notes related thereto and the related report of Bolinger, Segars, Gilbert & Moss, LLP . 99.2 Unaudited interim condensed consolidated financial statements of Amplex and its subsidiaries as of April 30, 2024 and 2023 and for the six months ended April 30, 2024 and 2023, including the notes related thereto and the related review report of Bolinger, Segars, Gilbert & Moss, LLP . 99.3 Unaudited pro forma condensed combined statements of operations of the Company and Amplex for the three months ended June 30, 2024 and 2023, respectively, and the notes related thereto.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. Signature Title Date /s/ Mike Rost Chief Executive Officer (Principal Executive Officer) August 29, 2024 Mike Rost /s/ Charlie Krebs Chief Financial Officer (Principal Financial and Accounting Officer) August 29, 2024 Charlie Krebs

View Full Filing

View this 8-K/A filing on SEC EDGAR